BWB Director Todd Urness Buys 1,164 Shares; Ownership 1.17M
Bridgewater Bancshares Inc (BWB) director Todd B. Urness reported an open-market purchase of 1,164 shares on 09/30/2025 at no reported cash price, bringing his total beneficial ownership to 1,173,722 shares.
Rhea-AI Filing Summary
Bridgewater Bancshares Inc (BWB) director Todd B. Urness reported an open-market purchase of 1,164 shares on 09/30/2025 at no reported cash price, bringing his total beneficial ownership to 1,173,722 shares. The filing was signed by an attorney-in-fact on 10/01/2025. The transaction is recorded on a Form 4 and reflects a director-level acquisition disclosed under Section 16.
Positive
- Director-level acquisition disclosed: Todd B. Urness reported acquiring 1,164 shares, increasing his total beneficial ownership to 1,173,722 shares
- Form 4 filed timely with signature by attorney-in-fact, indicating compliance with Section 16 reporting requirements
Negative
- None.
Insights
TL;DR Director purchased a small number of shares, modestly increasing insider ownership; routine Section 16 disclosure.
The Form 4 shows a director-level non-derivative acquisition of 1,164 common shares, raising total beneficial ownership to 1,173,722 shares. The filing contains no price information beyond a reported price of $0 (common in certain grant or correction filings), and no derivative transactions or disposals were reported. For investors, this is a routine insider disclosure without additional operational or financial details.
TL;DR Routine insider buy disclosure by a director; procedural compliance appears intact.
The entry identifies Todd B. Urness as a director and the sole reporting person for this Form 4. The form records an acquisition on 09/30/2025 and was signed by an attorney-in-fact on 10/01/2025. There is no indication of amendments, derivative activity, or change in reporting status. This filing meets Section 16 disclosure requirements but provides limited information for assessing governance impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,164 | $0.00 | $0.00 |
FAQ
Was a price disclosed for the BWB transaction?
Did the Form 4 report any derivative transactions or disposals for BWB?
When was the Form 4 for BWB signed and filed?
Does this Form 4 indicate any change in reporting status for the director?
AI-generated analysis. How Rhea-AI works. Not financial advice.